Activation of DNA biosynthesis in human hepatoblastoma HEPG2 cells by the nitric oxide donor, sodium nitroprusside

Fundamental and Clinical Pharmacology

Volumn 17, Issue 5, 2003, Pages 599-607

  Sokołowska, Maria ^a   Rokita, Hanna ^b   Włodek, Lidia ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

3H thymidine incorporation; Human hepatoma cell line; Nitric oxide; Nitroprusside

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; DOXORUBICIN; GLYCERYL TRINITRATE; HYDROGEN PEROXIDE; N ETHYLMALEIMIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; S NITROSOGLUTATHIONE; THYMIDINE; TOCOPHEROL; TRITIUM;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL DIVISION; CELL STIMULATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; STRESS;

CELL LINE, TUMOR; DNA; HEPATOBLASTOMA; HUMANS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; OXIDATION-REDUCTION;

EID: 0141482018     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2003.00182.x     Document Type: Article

References (46)

1. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. (1991) 43 109-142.
2. Bentz B.G., Simmons R.L., Haines G.K., Radosevich J.A. The yin and yang of nitric oxide: Reflections on the physiology and pathophysiology of NO. Head Neck (2000) 22 71-83.
3. Patel R.P., Levonen A.L., Crawford J.H., Darley-Usmar V.M. Mechanisms of the pro- and anti-oxidant actions of nitric oxide in artherosclerosis. Cardiovasc. Res. (2000) 47 465-474.
4. Brune B., Knethen A.V., Sandau K.B. Nitric oxide and its role in apoptosis. Eur. J. Pharmacol. (1998) 351 261-272.
5. Kim Y.M., Bombeck C.A., Billiar T. Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res. (1999) 84 253-256.
6. Jenkins D.C., Charles I.G., Thomson L.L. et al. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA (1995) 92 4392-4396.
7. Farias-Eisner R., Sherman M.P., Aeberhardt E., Chaudhari G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA (1994) 91 9407-9411.
8. Sciorati C., Nistico G., Meldolesi J., Clementi E. Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling. Br. J. Pharmacol. (1997) 122 687-697.
9. Reveneau S., Arnould L., Jolimoy G. et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab. Invest. (1999) 79 1215-1225.
10. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature (1993) 362 801-809.
11. Hajri A., Metzger E., Vallat F. et al. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies. Br. J. Cancer (1998) 78 841-849.
12. Cifone M.G., Cironi L., Meccia M.A. et al. Role of nitric oxide in cell-mediated tumor cytotoxicity. Adv. Neuroimmunol. (1995) 5 443-461.
13. Stuehr D.J., Nathan C.F Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. (1989) 169 1543-1555.
14. Hibbs J.B. Jr, Tainor R.R., Vavrin Z., Rachlin E.M Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. (1988) 157 87-94.
15. Ishii T., Sunami O., Nakajima H., Nishio H., Takeuchi T., Hata F. Critical role of sulfenic acid formation of thiols in the inactivation of glyceraldehyde-3-phosphate dehydrogenase by nitric oxide. Biochem. Pharmacol. (1999) 58 133-143.
16. Lepoivre M., Fieschi F., Coves J., Thelander L., Fonte-Cave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. (1991) 174 442-448.
17. Petit J.F., Nicaise M., Lepoivre M., Guisani A., Lemaire G. Protection by glutathione against the antiproliferative effects of nitric oxide. Dependence on kinetics of NO release. Biochem. Pharmacol. (1996) 52 205-212.
18. Stamler J.S. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiols groups. Curr. Top. Microbiol. Immunol. (1995) 196 19-36.
19. Broillet M.C. S-nitrosylation of protein. Cell Mol. Life Sci. (1999) 55 1036-1042.
20. Bates J.N., Baker M.T., Guerra R., Harrison D.G. Nitric oxide generation from nitroprusside by vascular tissue. Biochem. Pharmacol. (1991) 42 S157-S165.
21. Tian Y., Zhang C., Fang Z., Bells W.H. A hypothesis on the metabolism of glyceryl trinitrate in vascular endothelial cells. Clin. Chim. Acta (2001) 313 51-57.
22. Riss T.L., Sirbasku D.A. Growth and continuous passage of COMMA-D mouse mammary epithelial cells in hormonaly defined serum-free medium. Cancer Res. (1987) 47 3776-3782.
23. Marzinzig M., Nussler A.K., Stadler J. et al. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide (1997) 1 177-189
24. Al Sa'doni H., Ferro A. S-nitrosothiols: a class of nitric oxide donor drugs. Clin. Sci. (2000) 98 507-520.
25. Hogg N., Singh R.J., Konorev E., Joseph J., Kalyanaraman B. S-nitrosoglutathione as a substrate for γ-glutamyl transpeptidase. Biochem. J. (1997) 323 477-481.
26. Visvikis A., Goergen J.L., Oster T. et al. Gamma-glutamyl-transferase from human hepatoma cell lines: purification and cell culture of HepG2 on microcarriers. Clin. Chim. Acta (1990) 191 221-232.
27. Hausladen A., Stamler J.S. Nitrosative stress. Methods Enzymol. (1999) 300 389-395.
28. Juedes M.J., Wogan G.N. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat. Res. (1996) 349 51-61.
29. Szaleczky E., Pronai L., Nakazawa H., Tulassay Z Evidence of in vivo peroxynitrite formation in patients with colorectal carcinoma, higher plasma nitrate/nitrite levels and lower protection against oxygen free radicals. J. Clin. Gastroenterol. (2000) 30 47-57.
30. Munro A.P., Kiliams L.H. Reactivity of nitrogen nucleophiles towards S-nitrosopenicylamine. J Chem Soc Perkin Trans 1999 2 1989-1993.
31. Bauer G. Reactive oxygen and nitrogen species: efficient, selective and interactive signals during intercellular induction of apoptosis. Anticancer Res. (2000) 20 4115-4139.
32. Rao D.N., Elguindi S., O'Brien P. Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes. Arch. Biochem. Biophys. (1991) 286 30-37.
33. Niknahad H., O'Brien P.J. Involvement of nitric oxide in nitroprusside-induced hepatocyte cytotoxicity. Biochem. Pharmacol. (1996) 51 1031-1039.
34. Zidek Z., Masek K. Erratic behavior of nitric oxide within the immune system: illustrative review of conflicting data and their immunopharmacological aspects. Int. J. Immunopharmacol. (1998) 20 319-343.
35. Arroyo P.L., Hatch-Pigott V., Mouer H.F., Cooney R.V. Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res. (1992) 281 193-202.
36. Stosic-Grujicis S., Trajkovic V., Badovinac V., Mostarica Stojkovic M. Pentoxifylline potentiates nitric oxide production and growth, suppresion in interferon-gamma-treated L929 fibroblasts. Cell Immunol. (1998) 184 105-111.
37. Pignatti C., Tantini B., Stefanelli C, et al. Nitric oxide mediates either proliferation or cell death in cardiomyocytes. Involvement of polyamines. Amino Acids (1999) 6 181-190.
38. Frank S., Kampfer H., Podda M., Kaufmann R., Pfeilschifter J. Identification of copper/zinc superoxide dismutase as a nitric oxide-regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation. Biochem. J. (2000) 346 719-728.
39. Ulibarri J.A., Mozdziak P.E., Schultz E., Cook C., Best T.M. Nitric oxide donors, sodium nitroprusside and S-nitroso-N-acetyl-penicyllamine, stimulate myoblast proliferation in vitro. In Vitro Cell Dev. Biol. Anim. (1999) 35 215-218.
40. Huang Z.Z., Chen C., Zeng Z. et al. Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. FASEB J. (2001) 15 19-21.
41. Hanigan M.H., Gallagher B.C., Townsend D.M., Gabarra V. Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis (1999) 20 553-559.
42. Montironi R., Mazzucchelli R., Stramazzotti D., Pomante R., Thompson D., Bartel P.H. Expression of π-class glutathione S-transferase: two population of high grade prostatic intra-epithelial neoplasia with different relation to carcinoma. Mol. Pathol. (2000) 53 122-128.
43. Miller L.T., Watson W.H., Kirlin W.G., Ziegler T.R., Jones D.P. Oxidation of the glutathione disulfide redox state induced by cysteine deficiency in human colon carcinoma HT cells. J. Nutr. (2002) 2303-2306.
44. Swaroop G.R., Kelly P.A., Bell H.S., Shinoda J., Yamaguchi S., Whittle J.R. The effects of chronic nitric oxide synthase suppresion on glioma pathophysiology. Br. J. Neurosurg. 14 543-548.
45. Meister A. New developments in glutathione metabolism and their potential application in therapy. Hepatology (1984) 4 739-742.
46. Malendez J.A., Malethe R.P., Rodriquez A.M., Mazurkiewicz J.E., Davies K.J. Nitric oxide enhances the manganese superoxide dismutase dependent suppresion of proliferation in HT-1080 fibrosarcoma cell. Cell Growth. Differ. (1999) 10 655-664.